Stemtech (STEK) Change in Receivables (2021 - 2025)
Stemtech's (STEK) quarterly Change in Receivables came in at -$326487.0 in Q4 2025, down 933.43% year-on-year from $39174.0 in Q4 2024, and down 1457.82% quarter-over-quarter from -$20958.0 in Q3 2025.
Stemtech (STEK) Change in Receivables (2021 - 2025) Analysis & Trends
Stemtech has disclosed Change in Receivables across 5 years of filings, most recently posting -$326487.0 for Q4 2025.
- Change in Receivables for Q4 2025 came in at -$326487.0, down 933.43% year-over-year; the trailing twelve-month figure through Dec 2025 was -$269749.0 (down 229.53% YoY), and the FY2025 annual result was -$269749.0, down 229.53% from the prior year.
- Change in Receivables came in at -$326487.0 for Q4 2025 at Stemtech, down from -$20958.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $119208.0 in Q1 2021 to a low of -$326487.0 in Q4 2025.
- The 5-year median for Change in Receivables is $4488.0 (2022), against an average of -$1359.1.
- Across the five-year window, Change in Receivables soared 4384.7% in 2022 and tumbled 933.43% in 2025, its largest moves.
- Stemtech's Change in Receivables stood at -$1416.0 in 2021, then plunged by 252.19% to -$4987.0 in 2022, then slumped by 725.21% to -$41153.0 in 2023, then surged by 195.19% to $39174.0 in 2024, then sank by 933.43% to -$326487.0 in 2025.
- The last three Change in Receivables figures came in at -$326487.0 (Q4 2025), -$20958.0 (Q3 2025), and $87138.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 116.25 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.23 Mn |
| 10 | Stemtech | - | - | 354,677.00 | -326,487.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -326,487.00 |
| Dec 31, 2025 | -326,487.00 |
| Sep 30, 2025 | -20,958.00 |
| Sep 30, 2025 | -20,958.00 |
| Jun 30, 2025 | 87,138.00 |
| Jun 30, 2025 | 87,138.00 |
| Mar 31, 2025 | -9,442.00 |
| Mar 31, 2025 | -9,442.00 |
| Dec 31, 2024 | 39,174.00 |
| Dec 31, 2024 | 39,174.00 |
| Jun 30, 2024 | 113,871.00 |
| Jun 30, 2024 | 113,871.00 |
| Mar 31, 2024 | 55,210.00 |
| Mar 31, 2024 | 55,210.00 |
| Dec 31, 2023 | -41,153.00 |
| Dec 31, 2023 | -41,153.00 |
| Sep 30, 2023 | 79,477.00 |
| Sep 30, 2023 | 79,477.00 |
| Jun 30, 2023 | 10,635.00 |
| Jun 30, 2023 | 10,635.00 |